abstract |
HBV infection comprising administering to a subject in need thereof a first pharmaceutically acceptable agent that removes hepatitis B surface antigen from the blood and a second pharmaceutically acceptable agent that stimulates immune function Or a method of treating HBV / HDV co infection. |